Solana Company has announced plans to repurchase 5% of the total Solana token supply, valued at over $6 billion. CEO Joseph Che revealed the news in an interview with Chinese media.
Che, the former head of UBS Asia and current CEO of Helius Medical Technologies (HSDT), transformed the company into a Digital Asset Treasury (DAT) in less than a month, rebranding it as Solana Company. He also began building a Solana token reserve to support future operations.
The CEO noted that if the company reaches its target market capitalization and meets regulatory requirements, a listing in Hong Kong is planned, potentially within the next six months.
Che highlighted Solana’s technical advantages over Ethereum, including faster transaction speeds and a growing ecosystem of DeFi protocols and stablecoins built on the network.
Solana Company is supported by Xia Yan Capital and Pantera Investment and collaborates closely with the Solana Foundation to expand its presence in Asia. Earlier, Helius had raised over $500 million to acquire Solana tokens.
